Literature DB >> 12892170

Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis in Wiskott-Aldrich syndrome.

S Pasic1, D Micic, M Kuzmanovic.   

Abstract

UNLABELLED: A patient with Wiskott-Aldrich syndrome who developed Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis (EBV-HLH) is described in this study. At 4 mo of age the patient developed fever associated with bicytopenia and splenomegaly. Analysis of a bone marrow specimen revealed extensive haemophagocytosis, and in situ hybridization for EBV of the bone marrow specimen using an EBV-encoded RNA probe was positive. Diagnosis of EBV-HLH was established and immunotherapy with HLH-94 protocol was started. HLH has been described in patients with other well-defined primary immunodeficiencies such as X-linked lymphoproliferative syndrome, Chediak-Higashi syndrome and Griscelli disease. Also, HLH was reported recently in severe combined immunodeficiency and DiGeorge syndrome.
CONCLUSION: The possibility of an underlying primary immunodeficiency should be considered in paediatric patients who present with HLH during infancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892170     DOI: 10.1080/08035250310003631

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  10 in total

Review 1.  Natural killer cell cytotoxicity: how do they pull the trigger?

Authors:  Nicola J Topham; Eric W Hewitt
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

2.  The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.

Authors:  Sebastian Fn Bode; Sandra Ammann; Waleed Al-Herz; Mihaela Bataneant; Christopher C Dvorak; Stephan Gehring; Andrew Gennery; Kimberly C Gilmour; Luis I Gonzalez-Granado; Ute Groß-Wieltsch; Marianne Ifversen; Jenny Lingman-Framme; Susanne Matthes-Martin; Rolf Mesters; Isabelle Meyts; Joris M van Montfrans; Jana Pachlopnik Schmid; Sung-Yun Pai; Pere Soler-Palacin; Uta Schuermann; Volker Schuster; Markus G Seidel; Carsten Speckmann; Polina Stepensky; Karl-Walter Sykora; Bianca Tesi; Thomas Vraetz; Catherine Waruiru; Yenan T Bryceson; Despina Moshous; Kai Lehmberg; Michael B Jordan; Stephan Ehl
Journal:  Haematologica       Date:  2015-05-28       Impact factor: 9.941

Review 3.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

Review 4.  Clinical immunology review series: an approach to the patient with recurrent infections in childhood.

Authors:  M A Slatter; A R Gennery
Journal:  Clin Exp Immunol       Date:  2008-03-28       Impact factor: 4.330

5.  Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.

Authors:  DeepakBabu Chellapandian; Rupali Das; Kristin Zelley; Susan J Wiener; Huaqing Zhao; David T Teachey; Kim E Nichols
Journal:  Br J Haematol       Date:  2013-05-21       Impact factor: 6.998

Review 6.  Hemophagocytic syndrome in children and adults.

Authors:  Iwona Malinowska; Maciej Machaczka; Katarzyna Popko; Alicja Siwicka; Małgorzata Salamonowicz; Barbara Nasiłowska-Adamska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-02-09       Impact factor: 4.291

7.  Two Brothers with Atypical UNC13D-Related Hemophagocytic Lymphohistiocytosis Characterized by Massive Lung and Brain Involvement.

Authors:  Giuliana Giardino; Maia De Luca; Emilia Cirillo; Paolo Palma; Roberta Romano; Massimiliano Valeriani; Laura Papetti; Carol Saunders; Caterina Cancrini; Claudio Pignata
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

Review 8.  Current Flow Cytometric Assays for the Screening and Diagnosis of Primary HLH.

Authors:  Samuel Cern Cher Chiang; Jack J Bleesing; Rebecca A Marsh
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

9.  Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis.

Authors:  Ivan K Chinn; Olive S Eckstein; Erin C Peckham-Gregory; Baruch R Goldberg; Lisa R Forbes; Sarah K Nicholas; Emily M Mace; Tiphanie P Vogel; Harshal A Abhyankar; Maria I Diaz; Helen E Heslop; Robert A Krance; Caridad A Martinez; Trung C Nguyen; Dalia A Bashir; Jordana R Goldman; Asbjørg Stray-Pedersen; Luis A Pedroza; M Cecilia Poli; Juan C Aldave-Becerra; Sean A McGhee; Waleed Al-Herz; Aghiad Chamdin; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Tram N Cao; Diana N Hong; Richard A Gibbs; James R Lupski; Jordan S Orange; Kenneth L McClain; Carl E Allen
Journal:  Blood       Date:  2018-04-09       Impact factor: 25.476

Review 10.  The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile.

Authors:  Daria Brambilla; Cesare Mancuso; Mariagrazia Rita Scuderi; Paolo Bosco; Giuseppina Cantarella; Laurence Lempereur; Giulia Di Benedetto; Salvatore Pezzino; Renato Bernardini
Journal:  Nutr J       Date:  2008-09-30       Impact factor: 3.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.